fdl176
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 20, 2017 (NCT03173573)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fdl176
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03756922 | Phase 1 | Nov 27, 2018 | Flatley Discovery Lab LLC |
| NCT03516331 | Phase 1 | Mar 7, 2018 | Flatley Discovery Lab LLC |
| NCT03173573 | Phase 1 | Jun 20, 2017 | Flatley Discovery Lab LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Flatley Discovery Lab LLC | Academic/Hospital | 3 | 3 | 1 | 2017 |
1 organizations
Page 1 / 1